The France Foundation
AMA PRA Category 1
Listen to expert review of recent articles and review clinical applications of the findings.
After completing the course, participants will be able to:
- Differentiate between non-platform (newer) MS therapies, which can be considered when starting or switching treatment
- Examine criteria to determine whether to initiative or switch treatment